{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T14:37:06Z","timestamp":1786718226593,"version":"build-2736575974"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oman J Ophthalmol"],"published-print":{"date-parts":[[2012]]},"DOI":"10.4103\/0974-620x.99368","type":"journal-article","created":{"date-parts":[[2012,8,4]],"date-time":"2012-08-04T05:53:27Z","timestamp":1344059607000},"page":"79","source":"Crossref","is-referenced-by-count":31,"title":["Short-term results of intravitreal dexamethasone implant (OZURDEX\n                    <sup>\u00ae<\/sup>\n                    ) in treatment of recalcitrant diabetic macular edema: A case series"],"prefix":"10.4103","volume":"5","author":[{"given":"Pukhraj","family":"Rishi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekta","family":"Rishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshmi","family":"Kuniyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Mathur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0974-620X.99368-1","first-page":"555","volume-title":"Diabetic macular edema: Review and update","author":"Pelzek","year":"2002","journal-title":"Ophthalmol Clin North Am"},{"key":"key-10.4103\/0974-620X.99368-2","first-page":"70","volume-title":"Increased levels of vascular endothelial growth factor and interleukin-6 in the aqueous humor of diabetics with macular edema","author":"Funatsu","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0974-620X.99368-3","first-page":"1953","volume-title":"Penn state retina research group.Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: Vascular endothelial growth factor decreases occludin in retinal endothelial cells","author":"Antonetti","year":"1998","journal-title":"Diabetes"},{"key":"key-10.4103\/0974-620X.99368-4","unstructured":"Leopold IH. Nonsteroidal and steroidal anti-inflammatory agents. In: Sears M, Tarkkanen A, editors Surgical pharmacology of the eye. New York, NY: Raven Press; 1985. p. 83-133."},{"key":"key-10.4103\/0974-620X.99368-5","first-page":"309","volume-title":"Corticosteroids inhibit the expression of the vascular endothelial growth factor gene in human vascular smooth muscle cells","author":"Nauck","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"key-10.4103\/0974-620X.99368-6","unstructured":"Tennant JL. Cystoid maculopathy: 125 prostaglandins in ophthalmology. In: Emery JM, editor Current concepts in cataract surgery: Selected proceedings of the fifth biennial cataract surgical congress. St Louis, MO: CV Mosby; 1978. p. 360-2."},{"key":"key-10.4103\/0974-620X.99368-7","first-page":"667","volume-title":"Hydrocortisone decreases retinal endothelial cell water and solute flux coincident with increased content and decreased phosphorylation of occludin","author":"Antonetti","year":"2002","journal-title":"J Neurochem"},{"key":"key-10.4103\/0974-620X.99368-8","first-page":"249","volume-title":"Corticosteroids inhibit VEGF-induced vascular leakage in a rabbit model of blood-retinal and blood aqueous barrier breakdown","author":"Edelman","year":"2005","journal-title":"Exp Eye Res"},{"key":"key-10.4103\/0974-620X.99368-9","first-page":"1447","volume-title":"A randomized trial comparing intravitreal triamcinolone acetonide and focal\/grid photocoagulation for diabetic macular edema","author":"Diabetic","year":"2008","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0974-620X.99368-10","first-page":"57","volume-title":"Intravitreal injection of triamcinolone for diffuse diabetic macular edema","author":"Jonas","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/0974-620X.99368-11","first-page":"2044","volume-title":"Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: Three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial","author":"Sutter","year":"2004","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0974-620X.99368-12","first-page":"1533","volume-title":"Intravitreal triamcinolone for refractory diabetic macular edema: Two-year results of a doublemasked, placebo-controlled, randomized clinical trial","author":"Gillies","year":"2006","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0974-620X.99368-13","first-page":"920","volume-title":"Intravitreal triamcinolone for refractory diabetic macular edema","author":"Martidis","year":"2002","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0974-620X.99368-14","first-page":"233","volume-title":"Toxicity of high-dose intravitreal dexamethasone","author":"Nabih","year":"1991","journal-title":"Int Ophthalmol"},{"key":"key-10.4103\/0974-620X.99368-15","first-page":"259","volume-title":"Evaluation of the retinal toxicity and pharmacokinetics of dexamethasone after intravitreal injection","author":"Kwak","year":"1992","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/0974-620X.99368-16","first-page":"1370","volume-title":"Effect of intravitreal dexamethasone on ocular histopathology in a rabbit model of endophthalmitis","author":"Maxwell","year":"1991","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0974-620X.99368-17","first-page":"309","volume-title":"Dexamethasone DDS Phase II Study Group.Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema","author":"Kuppermann","year":"2007","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/0974-620X.99368-18","first-page":"95","volume-title":"Laser treatment in diabetic retinopathy","author":"Neubauer","year":"2007","journal-title":"Ophthalmologica"},{"key":"key-10.4103\/0974-620X.99368-19","first-page":"2146","volume-title":"Two-year outcomes of the ranibizumab for edema of the macula in diabetes (READ-2) study","author":"Nguyen","year":"2010","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0974-620X.99368-20","first-page":"1134","volume-title":"Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion","author":"Haller","year":"2010","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0974-620X.99368-21","first-page":"1101","volume-title":"SCORE study research group.A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: The standard care vs corticosteroid for retinal vein occlusion (SCORE) study report 5","author":"Ip","year":"2009","journal-title":"Arch Ophthalmol"}],"container-title":["Oman Journal of Ophthalmology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:32:37Z","timestamp":1786714357000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0974-620X.99368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012]]}},"alternative-id":["99368"],"URL":"https:\/\/doi.org\/10.4103\/0974-620x.99368","relation":{},"ISSN":["0974-620X"],"issn-type":[{"value":"0974-620X","type":"print"}],"subject":[],"published":{"date-parts":[[2012]]}}}